Hasson NA, Navarrete C, Montoya J

Language: Spanish
References: 20
Page: 234-238
PDF size: 115.78 Kb.

ABSTRACT

Primary focal hyperhidrosis affects 1-3% of the worldwide population. It starts at puberty and has a familiar component in 30-65% of cases. Excessive prespiration has personal, social and occupational implications. Generally, it is clinically diagnosed, without complementary tests needed. Aluminum Chloride (AC) appears as a first line of treatment. It has good results for axillary, palmar and plantar focal hyperhidrosis. It is less effective for craniofacial hyperhidrosis. Local irritation is the main drawback but it is a treatable complication. AC is an effective and widely used treatment for primary focal hyperhidrosi

REFERENCES

1. Schlereth T, Dieterich M, Birklein F. “Hyperhidrosis–causes and treatment of enhanced sweating”. Dtsch Arztebl Int 2009 Jan; 106(3): 32-37.

2. Haider A, Solish N. “Focal hyperhidrosis: diagnosis and management”. CMAJ 2005 Jan 4; 172(1): 69-75.

3. Vetrugno R, Liguori R, Cortelli P. “Sympathetic skin response: basic mechanisms and clinical applications”. Clin Auton Res 2003 Aug; 13(4): 256-270.

4. Benarroch EE. “Thermoregulation: recent concepts and remaining questions”. Neurology 2007 Sep 18; 69(12): 1293-1297.

5. Grunfeld A, Murray C, Nowell S. “Botulinum toxin for hyperhidrosis”. J Am Acad Dermatol 2009; 10(2): 87-102.

6. Fitzgerald E, Feeley TM, Tierney S. “Current treatments for axillary hyperhidrosis”. Surgeon 2004 Dec; 2(6): 311-314.

7. Thomas I, Brown J, Vafaie J. “Palmoplantar hyperhidrosis: a therapeutic challenge”. Am Fam Physician 2004 Mar 1; 69(5): 1117-1120.

8. Callejas MA, Grimalt R, Cladellas E. “Hyperhydrosis update”. Actas Dermosifiliogr 2010 Mar; 101(2): 110-118.

9. Togel B, Greve B, Raulin C. “Current therapeutic strategies for hyperhidrosis: a review”. Eur J Dermatol 2002 May-Jun; 12(3): 219-223.

10. Eisenach JH, Atkinson JL, Fealey RD. “Hyperhidrosis: evolving therapies for a well-established phenomenon”. Mayo Clin Proc 2005 May; 80(5): 657-666.

11. Strutton DR, Kowalski JW, Glaser DA. “US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey”. J Am Acad Dermatol 2004 Aug; 51(2): 241-28.

12. Solish N, Bertucci V, Dansereau A. “A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee”. Dermatol Surg 2007 Aug; 33(8): 908-923.

13. Burkhart CG, Burkhart CN. “Aluminum alters sweating by constricting the dermal duct lumen”. Int J Dermatol 2008 Dec; 47(12): 1306-1307.

14. Scholes KT, Crow KD, Ellis JP. “Axillary hyperhidrosis treated with alcoholic solution of aluminium chloride hexahydrate”. Br Med J 1978 Jul 8; 2(6130): 84-85.

15. Ellis H, Scurr JH. “Axillary hyperhidrosis –topical treatment with aluminium chloride hexahydrate”. Postgrad Med J 1979 Dec; 55(654): 868-869.

16. Rayner CR, Ritchie ID, Stark GP. “Axillary hyperhidrosis, 20% aluminum chloride hexahydrate, and surgery”. Br Med J 1980 May 10; 280(6224): 1168.

17. Goh CL. “Aluminum chloride hexahydrate versus palmar hyperhidrosis. Evaporimeter assessment”. Int J Dermatol 1990 Jun; 29(5): 368-370.

18. Benohanian A, Dansereau A, Bolduc C. “Localized hyperhidrosis treated with aluminum chloride in a salicylic acid gel base”. Int J Dermatol 1998 Sep; 37(9): 701-703.

19. Woolery-Lloyd H, Valins W. “Aluminum chloride hexahydrate in a salicylic acid gel: a novel topical agent for hyperhidrosis with decreased irritation”. J Clin Aesthet Dermatol 2009 Jun; 2(6): 28-31.

20. Black MJ, Gunn A. “The management of Frey’s syndrome with aluminium chloride hexahydrate antiperspirant”. Ann R Coll Surg Engl 1990 Jan; 72(1): 49-52.